Compare PEPG & LOCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PEPG | LOCO |
|---|---|---|
| Founded | 2018 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 317.6M | 325.6M |
| IPO Year | 2022 | 2014 |
| Metric | PEPG | LOCO |
|---|---|---|
| Price | $5.47 | $10.89 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 4 |
| Target Price | $10.80 | ★ $14.50 |
| AVG Volume (30 Days) | ★ 684.0K | 181.1K |
| Earning Date | 02-23-2026 | 03-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 13.62 |
| EPS | N/A | ★ 0.89 |
| Revenue | N/A | ★ $480,815,000.00 |
| Revenue This Year | N/A | $5.44 |
| Revenue Next Year | N/A | $1.64 |
| P/E Ratio | ★ N/A | $12.30 |
| Revenue Growth | N/A | ★ 2.09 |
| 52 Week Low | $0.88 | $8.29 |
| 52 Week High | $7.80 | $12.65 |
| Indicator | PEPG | LOCO |
|---|---|---|
| Relative Strength Index (RSI) | 46.18 | 45.43 |
| Support Level | $5.31 | $10.83 |
| Resistance Level | $6.20 | $11.24 |
| Average True Range (ATR) | 0.57 | 0.31 |
| MACD | -0.11 | -0.02 |
| Stochastic Oscillator | 23.03 | 35.37 |
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.
El Pollo Loco Holdings Inc operates and franchises hundreds of fast-casual chicken restaurants in the United States. Restaurant locations are typically free-standing and include drive-thrus, and menus include many low-priced options. Poultry is the company's largest food cost, accounting for roughly 38% of total food and paper cost, and the company manages that commodity price risk by using multiple suppliers and entering supply contracts of varying lengths depending on market conditions.